| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 02/01/2001 | WO2001007020A2 Carboxylic acid amides, medicaments containing these compounds and the use and production thereof |
| 02/01/2001 | WO2000058405A3 Squaraine dyes |
| 02/01/2001 | DE19935219A1 Carbonsäureamide, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Herstellung Carboxamides, medicaments containing these compounds, their use and production |
| 02/01/2001 | CA2393110A1 Electron-driven chirality switches |
| 02/01/2001 | CA2378860A1 Bicyclic antagonists selective for the .alpha.v.beta.3 integrin |
| 01/31/2001 | EP1072587A1 Sulfonamide derivatives and drugs containing the same as the active ingredient |
| 01/31/2001 | EP1072263A1 Amide derivatives and nociceptin antagonists |
| 01/31/2001 | EP1071669A1 Bicyclic compounds having an anti-thrombitic effect |
| 01/31/2001 | EP1071656A1 Fluorovinyloxyacetamides, process for preparing same and herbicidal composition comprising same |
| 01/31/2001 | EP1071648A2 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 01/31/2001 | CN1282321A Potassium channel openers |
| 01/31/2001 | CN1282319A Aminobutanoic acid derivatives |
| 01/31/2001 | CN1061351C Intermediates diaza or oxadiazabicyclic compounds |
| 01/31/2001 | CN1061339C Novel sulfonamide inhibitors of aspartyl protease |
| 01/30/2001 | US6180675 IL-8 receptor antagonists |
| 01/30/2001 | US6180632 Use of these compounds for treating disorders/conditions involving cellular differentiation, proliferation, extracellular matrix production or mediator release and/or t cell activation and proliferation |
| 01/30/2001 | CA2191352C Quinoline derivatives as tachykinin nk3 receptor antagonists |
| 01/25/2001 | WO2001005783A1 Bradykinin b1 receptor antagonists |
| 01/25/2001 | WO2001005767A1 Organic compounds |
| 01/25/2001 | CA2379064A1 Bradykinin b1 receptor antagonists |
| 01/24/2001 | EP1070054A1 Amine compounds, their production and their use as somatostatin receptor antagonists or agonists |
| 01/24/2001 | EP1070052A1 Fungicide compositions comprising a hydroximic or hydrazonic group |
| 01/24/2001 | EP1069901A1 Calcilytic compounds and method of use |
| 01/24/2001 | CN1281439A 4-Hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents |
| 01/24/2001 | CN1281436A N-Benzyl-3-indenylacetamides derivatives for treating neoplasia |
| 01/24/2001 | CN1281430A N-alkanoylphenylalanine derivatives |
| 01/23/2001 | US6177446 Synergistic |
| 01/23/2001 | US6177428 Treatment of sexual dysfunction; stimulation of endogenous nitrogen monoxide synthesis |
| 01/18/2001 | WO2001004102A1 Quinazoline derivatives |
| 01/18/2001 | WO2000034245A3 Crystalline form of benzoquinoline-3-one derivatve as inhibitor of 5-alpha reductase |
| 01/18/2001 | WO1999064049A9 Novel antibacterial agents |
| 01/18/2001 | CA2378291A1 Quinazoline derivatives |
| 01/17/2001 | EP1068193A1 Benzylpiperazinyl- and benzylpiperidinyl ethanone derivatives, their preparation and their use as dopamine d 4? receptor antagonists |
| 01/17/2001 | EP1068178A1 NON-PEPTIDE GnRH AGENTS |
| 01/17/2001 | EP1067894A2 Protease inhibitors |
| 01/17/2001 | EP0983258A4 N-hydroxy 4-sulfonyl butanamide compounds |
| 01/17/2001 | CN1280572A Inhibiting platelet derivative growth factor and/or quinoline and quinowoline compounds of P56lek tyrosinkinase |
| 01/17/2001 | CN1280569A 1,2-dihydro-2-oxoquinoline derivatives |
| 01/17/2001 | CN1280568A Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
| 01/17/2001 | CN1280561A Amidocarboxylic acid derivatives |
| 01/16/2001 | US6174924 Treating nerve cell death comprising administering to a subject exhibiting symptoms of nerve cell death or susceptible to nerve cell death a substituted guanidine compound |
| 01/16/2001 | US6174905 As carcinostatic agent to a hematologic malignancy and a solid carcinoma |
| 01/16/2001 | US6174897 For treatment of brain dissorders such as dementia, depression, myotonic dystrophy, alcoholism and other addiction diseases, sleep disturbances and bronchial asthma, presenile alzheimer's disease |
| 01/16/2001 | US6174889 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 01/11/2001 | WO2001002396A1 Novel benzo[f]naphthyridine, preparation and compositions containing them |
| 01/11/2001 | WO2001002368A1 N-heterocyclic derivatives with neuronal activity |
| 01/11/2001 | WO2001002365A1 Ciprofloxacin hydrates and method for their production |
| 01/10/2001 | EP1066259A1 Biocidal benzylbiphenyl derivatives |
| 01/10/2001 | CN1279683A Method for producing f-methoxy-quinoline carboxylic acids |
| 01/09/2001 | US6172261 Biosynthesis using chain extension |
| 01/09/2001 | US6172113 Bicyclic amino derivatives and PGD2 antagonist containing the same |
| 01/09/2001 | US6172108 Hydrazide compounds |
| 01/09/2001 | US6172095 Decongestants, analgesics, hypotensive agents; treating headaches, otitis media, sinusitus, gastrointestinal and respiratory system disorders; side effect reduction |
| 01/09/2001 | US6172084 Quinoline-indole antimicrobial agents, uses and compositions related thereto |
| 01/09/2001 | US6172083 Applying 4-phenoxyquinoline and 3-(halophenyl)-4-cyanopyrrole derivatives as synergistic mixture |
| 01/09/2001 | US6172082 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 01/09/2001 | US6172068 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 01/09/2001 | US6172060 Therapy for sexual disorders |
| 01/09/2001 | US6172057 Antiinflammatory agents; antiarthritic agents; antitumor agents |
| 01/04/2001 | WO2001000582A1 Preparation of quinoline-substituted carbonate and carbamate derivatives |
| 01/04/2001 | WO2001000579A1 COMPOUNDS FOR THE MODULATION OF PPARη ACTIVITY |
| 01/04/2001 | WO2001000209A1 Methods of use of fluoroquinolone compounds against bacteria |
| 01/04/2001 | DE19930557A1 Hydrate von Ciprofloxacin und Verfahren zu ihrer Herstellung Hydrates of ciprofloxacin and processes for their preparation |
| 01/04/2001 | CA2850203A1 Preparation of quinoline-substituted carbonate and carbamate derivatives |
| 01/04/2001 | CA2719425A1 Preparation of quinoline-substituted carbonate and carbamate derivatives |
| 01/03/2001 | EP1065203A2 Heterocyclic compounds as retinoic acid receptor antagonists |
| 01/03/2001 | EP1064264A1 Cytotoxic metal chelators and methods for making and using same |
| 01/03/2001 | CN1278813A Antimicrobial quinolones, their compositions and uses |
| 01/03/2001 | CN1278796A Method for the synthesis of quinoline derivatives |
| 01/03/2001 | CN1278793A Sulfonyl derivatives |
| 01/02/2001 | US6169096 For inhibiting tumor growth in a mammal |
| 01/02/2001 | US6169095 For prevention and/or treatment of bradykinin or its analogues mediated diseases in the eye, such as allergy, inflammation and pain of the eye |
| 01/02/2001 | US6169088 1,3 diazines with platelet-derived growth factor receptor inhibitory activity |
| 01/02/2001 | US6169085 A viricide for preventing and treating retroviral infection or the spread of a retrovirus, inhibiting replication of a retrovirus and treating aids |
| 01/02/2001 | CA2013449C Antibacterial 5-alkylquinolonecarboxylic acids |
| 01/02/2001 | CA1341163C Oxime ether derivatives, their preparation and fungicides containing these derivatives |
| 12/28/2000 | WO2000078768A1 Potassium channel openers |
| 12/28/2000 | WO2000078748A1 Quinoline derivatives as antibacterials |
| 12/28/2000 | WO2000078735A1 Bicyclic heterocycles, medicaments containing these compounds, their use and methods for the production thereof |
| 12/28/2000 | DE19928306A1 New 4-amino-quinazoline or quinoline derivatives, are tyrosine kinase-mediated signal transduction inhibitors useful e.g. for treating tumors, polyps or respiratory or gastrointestinal diseases |
| 12/28/2000 | DE19928281A1 Arylamino and aralkylamino substituted quinoline and quinazoline derivatives, useful for the treatment of e.g. tumors, pulmonary, respiratory and gastrointestinal disorders and psoriasis |
| 12/28/2000 | CA2375282A1 Potassium channel openers |
| 12/27/2000 | EP1063233A1 Process for the preparation of 2-quinolinylthio-acetic acid and its hydrochloride |
| 12/27/2000 | EP1062218A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 12/27/2000 | EP1062217A1 Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives |
| 12/27/2000 | EP0639050B1 Synergistic composition and process for selective weed control |
| 12/27/2000 | CN1278257A Processes for producing 7-isoindolinequinolonecarboxylic derivatives and intermediates therefor, solts of 7-isoindo-linequinolonecarboxylic acid, hydrates thereof, and composition contg. same |
| 12/27/2000 | CN1278244A Dipeptide nitriles |
| 12/26/2000 | US6166057 Fungicides for the control of take-all disease of plants |
| 12/26/2000 | US6166053 Antiproliferative agent for treating cancer |
| 12/26/2000 | US6166020 Aryl and heteroaryl alkoxynaphthalene derivatives |
| 12/21/2000 | WO2000077027A2 Serine protease inhibitors |
| 12/21/2000 | WO2000076982A1 Antagonism of immunostimulatory cpg-oligonucleotides by 4-aminoquinolines and other weak bases |
| 12/21/2000 | WO2000076981A1 Piperidinyl and piperazinyl substituted benzofused lactams |
| 12/21/2000 | WO2000076971A2 Serine protease inhibitors |
| 12/21/2000 | WO2000076970A2 Serine protease inhibitors |
| 12/21/2000 | WO2000076957A1 N-alkoxyalkyl-n,n-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same |
| 12/21/2000 | WO2000076495A1 Il-8 receptor antagonists |
| 12/21/2000 | WO2000044709A3 ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS |
| 12/21/2000 | CA2412345A1 Antagonism of immunostimulatory cpg-oligonucleotides by 4-aminoquinolines and other weak bases |